Gene · 1902
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Trim69 is a microtubule regulator that acts as a pantropic viral inhibitor. | Proc Natl Acad Sci U S A | 2022 | 36251989 | PubTator, text mining | PubMed |
| The Application of Complementary and Alternative Medicine in Polycystic Ovary Syndrome Infertility. | Evid Based Complement Alternat Med | 2022 | 36248406 | PubTator, text mining | PubMed |
| Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors. | Mediators Inflamm | 2022 | 36248188 | PubTator, text mining | PubMed |
| Biomarkers of gastric cancer: current advancement. | Heliyon | 2022 | 36247151 | PubTator, text mining | PubMed |
| Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective. | Front Pharmacol | 2022 | 36238572 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Particulate Matter 2.5-Induced Abnormal Effects on Human Sebocytes. | Int J Mol Sci | 2022 | 36232834 | PubTator, text mining | PubMed |
| Exploration of biomedical knowledge for recurrent glioblastoma using natural language processing deep learning models. | BMC Med Inform Decis Mak | 2022 | 36229835 | PubTator, text mining | PubMed |
| Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics. | Front Oncol | 2022 | 36212395 | PubTator, text mining | PubMed |
| Lysophosphatidic acid-induced amphiregulin secretion by cancer-associated fibroblasts augments cancer cell invasion. | Cancer Lett | 2022 | 36209972 | PubTator, text mining | PubMed |
| Identification of inflammatory-related gene signatures to predict prognosis of endometrial carcinoma. | BMC Genom Data | 2022 | 36207698 | PubTator, text mining | PubMed |
| Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study. | Pain Ther | 2022 | 36205847 | PubTator, text mining | PubMed |
| Guanine inhibits the growth of human glioma and melanoma cell lines by interacting with GPR23. | Front Pharmacol | 2022 | 36199684 | PubTator, text mining | PubMed |
| Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors. | J Chem Inf Model | 2022 | 36195573 | PubTator, text mining | PubMed |
| Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present). | Expert Opin Ther Pat | 2022 | 36175357 | PubTator, text mining | PubMed |
| KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers. | World J Gastrointest Oncol | 2022 | 36160748 | PubTator, text mining | PubMed |
| Ji-Chuan decoction ameliorates slow transit constipation via regulation of intestinal glial cell apoptosis. | World J Gastroenterol | 2022 | 36160643 | PubTator, text mining | PubMed |
| Multitargeting nature of muscarinic orthosteric agonists and antagonists. | Front Physiol | 2022 | 36148314 | PubTator, text mining | PubMed |
| Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy. | Int J Mol Sci | 2022 | 36142408 | PubTator, text mining | PubMed |
| Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects. | Eur J Med Chem | 2022 | 36126387 | PubTator, text mining | PubMed |
| Structure of the active Gi-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist. | Nat Commun | 2022 | 36109516 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1902/papers?page=19